Lord, Abbett & Co. LLC Deciphera Pharmaceuticals, Inc. Transaction History

Lord, Abbett & Co. LLC

$31.4 Billion
Q3 2024

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 11, 2021	SELL	$40.39 - $56.73 $13.8 Million - $19.4 Million	-342,274 Closed	0 $0
Q4 2020 Feb 09, 2021	SELL	$51.77 - $66.18 $2.99 Million - $3.82 Million	-57,725 Reduced 14.43%	342,274 $19.5 Million
Q3 2020 Nov 12, 2020	BUY	$43.8 - $58.16 $665,497 - $883,683	15,194 Added 3.95%	399,999 $20.5 Million
Q2 2020 Aug 14, 2020	SELL	$37.05 - $65.03 $341,415 - $599,251	-9,215 Reduced 2.34%	384,805 $23 Million
Q1 2020 May 14, 2020	SELL	$33.63 - $69.4 $6.63 Million - $13.7 Million	-197,017 Reduced 33.33%	394,020 $16.2 Million
Q4 2019 Feb 14, 2020	BUY	$31.7 - $69.93 $8.2 Million - $18.1 Million	258,717 Added 77.85%	591,037 $36.8 Million
Q3 2019 Nov 14, 2019	SELL	$19.95 - $38.85 $442,550 - $861,809	-22,183 Reduced 6.26%	332,320 $11.3 Million
Q2 2019 Aug 14, 2019	BUY	$21.05 - $26.21 $976,109 - $1.22 Million	46,371 Added 15.05%	354,503 $7.99 Million
Q1 2019 May 15, 2019	BUY	$20.65 - $29.55 $1.48 Million - $2.11 Million	71,525 Added 30.23%	308,132 $7.15 Million
Q4 2018 Feb 14, 2019	SELL	$19.08 - $36.14 $2.39 Million - $4.53 Million	-125,417 Reduced 34.64%	236,607 $4.97 Million
Q3 2018 Nov 14, 2018	BUY	$33.57 - $42.1 $115,447 - $144,781	3,439 Added 0.96%	362,024 $14 Million
Q2 2018 Aug 14, 2018	BUY	$20.06 - $44.95 $165,575 - $371,017	8,254 Added 2.36%	358,585 $14.1 Million
Q1 2018 May 15, 2018	BUY	$20.04 - $29.71 $1.61 Million - $2.38 Million	80,207 Added 29.69%	350,331 $7.02 Million
Q4 2017 Feb 14, 2018	BUY	$16.54 - $24.2 $1.49 Million - $2.18 Million	90,124 Added 50.07%	270,124 $6.12 Million
Q3 2017 Nov 14, 2017	BUY	$17.65 - $18.99 $3.18 Million - $3.42 Million	180,000	180,000 $3.42 Million

Others Institutions Holding DCPH

# of Institutions

Shares Held

293K

Call Options Held

500

Put Options Held

View Full List

About Deciphera Pharmaceuticals, Inc.

Ticker DCPH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 66,822,100
Description
Deciphera Pharmaceuticals, Inc., a biopharmaceutical company, develops drugs to enhance the lives of cancer patients by addressing key mechanisms of drug resistance that limit the rate and durability of response to existing cancer therapies in the United States and internationally. Its lead drug candidate is QINLOCK used for the treatment of gas...

More about DCPH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lord, Abbett & Co. LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lord, Abbett & Co. LLC with notifications on news.

Account